Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Vorasidenib and grading of IDH mutant astrocytoma

Vorasidenib and grading of IDH mutant astrocytoma

FromNeuro-Oncology: The Podcast


Vorasidenib and grading of IDH mutant astrocytoma

FromNeuro-Oncology: The Podcast

ratings:
Length:
24 minutes
Released:
Oct 27, 2023
Format:
Podcast episode

Description

Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
Released:
Oct 27, 2023
Format:
Podcast episode

Titles in the series (79)

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.